These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11529251)

  • 1. Rates of verbal fluency decline in the longitudinal assessment of Alzheimer's disease.
    Fernández T; Santos S; Casadevall T; Pascual LF
    Neurologia; 2001; 16(6):285-6. PubMed ID: 11529251
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months.
    Rockwood K; Dai D; Mitnitski A
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):207-14. PubMed ID: 17621382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: clinical evaluation and disease management--update.
    Richter RW
    J Okla State Med Assoc; 2004 Dec; 97(12):546-54; quiz 555-6. PubMed ID: 15732886
    [No Abstract]   [Full Text] [Related]  

  • 5. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Alzheimer's disease].
    Bombois S; Lebert F; Vellas B; Pasquier F
    Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
    Lopez OL; Becker JT; Saxton J; Sweet RA; Klunk W; DeKosky ST
    J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F; Portet F; Touchon J; Vellas B
    J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors for Alzheimer's disease.
    Hitzeman N
    Am Fam Physician; 2006 Sep; 74(5):747-9. PubMed ID: 16970018
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of Alzheimer's disease.
    Grossberg GT
    J Clin Psychiatry; 2003; 64 Suppl 9():3-6. PubMed ID: 12934967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-referential tags in the discourse of people with Alzheimer's disease.
    Asp E; Song X; Rockwood K
    Brain Lang; 2006 Apr; 97(1):41-52. PubMed ID: 16146646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathologic changes in Alzheimer's disease.
    Wenk GL
    J Clin Psychiatry; 2003; 64 Suppl 9():7-10. PubMed ID: 12934968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

  • 14. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for managing Alzheimer's disease: Part II. Treatment.
    Cummings JL; Frank JC; Cherry D; Kohatsu ND; Kemp B; Hewett L; Mittman B
    Am Fam Physician; 2002 Jun; 65(12):2525-34. PubMed ID: 12086242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should one stop cholinesterase inhibitors in patients with Alzheimer's disease?
    Bogardus ST
    J Psychiatry Neurosci; 2001 Nov; 26(5):425. PubMed ID: 11762210
    [No Abstract]   [Full Text] [Related]  

  • 17. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease. Answers to some of your questions.
    Mayo Clin Womens Healthsource; 2004 May; 8(5):1-2. PubMed ID: 15088007
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternatives for Alzheimer's. Three basic approaches offer help and hope.
    Reese D
    Contemp Longterm Care; 2002 Feb; 25(2):8-9. PubMed ID: 11842532
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's disease. Accurate and early diagnosis in the primary care setting.
    Marin DB; Sewell MC; Schlechter A
    Geriatrics; 2002 Feb; 57(2):36-40; quiz 43. PubMed ID: 11851205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.